Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
83.3M
-
Number of holders
-
895
-
Total 13F shares, excl. options
-
77.7M
-
Shares change
-
+1.7M
-
Total reported value, excl. options
-
$17.8B
-
Value change
-
+$397M
-
Put/Call ratio
-
1.48
-
Number of buys
-
396
-
Number of sells
-
-420
-
Price
-
$229.32
Significant Holders of LABCORP HOLDINGS INC. - Common Stock (LH) as of Q4 2024
1,007 filings reported holding LH - LABCORP HOLDINGS INC. - Common Stock as of Q4 2024.
LABCORP HOLDINGS INC. - Common Stock (LH) has 895 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.7M shares
of 83.3M outstanding shares and own 93.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.65M shares), BlackRock, Inc. (9.32M shares), STATE STREET CORP (3.7M shares), GEODE CAPITAL MANAGEMENT, LLC (2M shares), DIAMOND HILL CAPITAL MANAGEMENT INC (1.97M shares), Allspring Global Investments Holdings, LLC (1.92M shares), Bank of New York Mellon Corp (1.82M shares), FMR LLC (1.62M shares), Select Equity Group, L.P. (1.6M shares), and CITADEL ADVISORS LLC (1.43M shares).
This table shows the top 895 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.